Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q1 2014 · 10-Q
Revenue$0.00$0.00— vs Q1 2013 Net Income-$650.30K-$650.30KN/M vs Q1 2013 EPS Diluted$0.00$0.00— vs Q1 2013 Operating Income-$652,386N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Free Cash Flowderived-$155,122N/M ended Mar 31, 2014 · filed May 15, 2014 · 45 d after period end